Parallax Volatility Advisers’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,000
Closed -$236K 3266
2022
Q4
$236K Hold
30,000
﹤0.01% 2088
2022
Q3
$185K Hold
30,000
﹤0.01% 2337
2022
Q2
$159K Buy
+30,000
New +$181K ﹤0.01% 2259
2018
Q3
Sell
-1,100
Closed -$16K 3769
2018
Q2
$16K Hold
1,100
﹤0.01% 1701
2018
Q1
$13K Sell
1,100
-600
-35% -$6.49K ﹤0.01% 1796
2017
Q4
$13K Buy
+1,700
New +$14K ﹤0.01% 3767

Other funds holding ZYME

Parallax Volatility Advisers's ZYME Position: Q1 2023 in Review

Parallax Volatility Advisers sold out of Zymeworks (ZYME) in Q1 2023, closing a stake of 30,000 shares — an estimated $236K sold.

Parallax Volatility Advisers first reported a position in ZYME in Q4 2017 and held it in 6 quarters. The position peaked at $236K in Q4 2022. 115 funds tracked by Wall St. Rank hold ZYME as of Q1 2023.

  • Parallax Volatility Advisers reported no remaining Zymeworks position as of Q1 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 30,000 Zymeworks shares in Q1 2023, an estimated $236K.
  • Parallax Volatility Advisers first reported a position in Zymeworks in Q4 2017 and held it in 6 quarters.
  • Parallax Volatility Advisers's Zymeworks position peaked at $236K in Q4 2022.
  • 115 funds tracked by Wall St. Rank held Zymeworks as of Q1 2023.

Based on Parallax Volatility Advisers's 13F filing for Q1 2023, filed 15 May 2023.